CN1583108A - Health care product of hippophae rhamnoides oil - Google Patents

Health care product of hippophae rhamnoides oil Download PDF

Info

Publication number
CN1583108A
CN1583108A CN 200410042755 CN200410042755A CN1583108A CN 1583108 A CN1583108 A CN 1583108A CN 200410042755 CN200410042755 CN 200410042755 CN 200410042755 A CN200410042755 A CN 200410042755A CN 1583108 A CN1583108 A CN 1583108A
Authority
CN
China
Prior art keywords
health product
hippophae
lecithin
vitamin
seed oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200410042755
Other languages
Chinese (zh)
Other versions
CN1262284C (en
Inventor
商宇
黄耀江
吕永利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caoyuan-Xingfa Co Ltd Inner Mongolian Autonomous Region
Original Assignee
Caoyuan-Xingfa Co Ltd Inner Mongolian Autonomous Region
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caoyuan-Xingfa Co Ltd Inner Mongolian Autonomous Region filed Critical Caoyuan-Xingfa Co Ltd Inner Mongolian Autonomous Region
Priority to CN 200410042755 priority Critical patent/CN1262284C/en
Publication of CN1583108A publication Critical patent/CN1583108A/en
Application granted granted Critical
Publication of CN1262284C publication Critical patent/CN1262284C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A health-care food for resisting oxidization and protecting cardial vessel is prepared from purified seabuckthorn oil, lecithin and VE.

Description

A kind of Oleum Hippophae health product
Technical field
The present invention relates to a kind of nutrient and healthcare products, specifically a kind of Oleum Hippophae health product with antioxidation, the effect of protection cardiovascular.
Background technology
In recent years, cardiovascular diseases's prevalence, sickness rate and cause that cardiovascular diseases's risk factor is continuous ascendant trend, China cardiovascular diseases's mortality rate accounts for crude death rate's 40% according to statistics.Coronary heart disease, myocardial infarction and by generation, the development of it cardiovascular disease such as arrhythmia that cause, all in blood vessel wall and other internal organs, deposit with lipid, and formation atherosclerosis, and the consequence that produces the blood flow change is relevant, in addition, along with the raising of people's living standard and the change of dietary structure, make the sickness rate of hyperlipemia be obvious ascendant trend, not only exist among the patient that hospital seeks medical advice, even in normal population, also become common phenomenon.These people are huge reserve crowds that possible develop into the severe cardiac cerebrovascular disease, and according to the principle of " putting prevention first ", early prevention, early treatment are particularly important.
At present the clinical medicine that is used for the treatment of be mostly effect single, respectively have and lay particular stress on, can not fundamentally treat disease and suppress the chemicals that disease is sent out, as: medicines such as blood vessel dilating, vessel softening, thrombus, dilute blood, these medicines have side effect, should not take for a long time.
Summary of the invention
The objective of the invention is to from the angle of effecting a permanent cure, by improving lipid metabolism, thereby improve blood flow etc., a kind of Oleum Hippophae health product with the effect of protection cardiovascular are provided.
Oleum Hippophae health product of the present invention are made up of the activated feedstock of following weight portion proportioning: 80~99 parts of purification Fructrs Hippophae seed oil, 0.5~3 part in lecithin, 0.5~3 part of vitamin E.
Oleum Hippophae health product preferred version of the present invention is made up of the activated feedstock of following weight portion proportioning: 90~98 parts of purification Fructrs Hippophae seed oil, 1~2 part in lecithin, vitamin e1~2 part.
Oleum Hippophae health product preferred plan of the present invention is made up of the activated feedstock of following weight portion proportioning: 96 parts of purification Fructrs Hippophae seed oil, 1 part in lecithin, vitamin e1 part.
Oleum Hippophae health product preparation method of the present invention is: take by weighing purification Fructrs Hippophae seed oil, lecithin, vitamin E mixing stirring according to the above ratio, homogenate makes active ingredient compositions of the present invention.
By existing processing technology, can be processed into various dosage forms, as: oral liquid, soft capsule etc.
Fructrs Hippophae seed oil is a kind of medicinal food that contains multivitamin, various trace elements, several amino acids and other biological active substance, serum triglycerides (TG) and two kinds of indexs of cholesterol (TC) of hyperlipemic patients are descended, and serum high-density LP (HDL) is raise, thereby blood lipid regulation, the generation of prevention cardiovascular and cerebrovascular disease.Lecithin can embed the cholesterol in the film effectively as the biomembrane component, by promoting the lipid circulation, quickens cholesterol metabolism.Atheromatous plaque on the blood vessel wall is directly dissolved in the vitamin E peroxidating of lipid in the occlude blood effectively.Fructrs Hippophae seed oil, lecithin, vitamin E etc. all have significant therapeuticing and health effect to cardiovascular, and the triplicity prescription can be realized having complementary functions and give full play to synergistic function between the component.
Oleum Hippophae health product of the present invention have following advantage through animal function test and the edible evidence of crowd:
1, acute toxicity test and subacute toxicity test explanation, Oleum Hippophae health product of the present invention are without any side effects, meet the requirement and the development trend of health product.
2, Oleum Hippophae health product of the present invention are taken by daily, from old complaint start with, strengthening the body resistance, by improving lipid metabolism, sedimentary blood fat on the free blood vessel wall of dissolving, blood fat reducing content improves the ability that blood transports oxygen and nutrient substance, eliminate the microthrombus of blood capillary, prevent that free radical from forming, thereby the pathogenesis basis that thoroughly cuts off the cardiovascular diseases effects a radical cure its recurrence, safe and efficient, reached the effect of Comprehensive Treatment.
3, Oleum Hippophae health product of the present invention are fit to hypertension, hyperlipidemia and elderly population, take by daily, can reach the cardiovascular purpose of protection.Through to the investigation on probation on ground such as the Inner Mongol, Beijing, Jilin, Liaoning, 360 philtrum triglycerides and cholesterol obviously descend 328 people, accounts for 91%; Unfruitful have 32 people, accounts for 9%.
[case 1]: Wang Guizhen, the woman, 56 years old, Hongshan District outskirts of a town, Chifeng City remote countryside man ditch village, the peasant, suffering from hyperlipidemia has recent two decades history.Once took good multiple medicine, but effect is all not obvious.Since taking this Oleum Hippophae health product after 2 months, through checking that in hospital's blood count blood fat obviously descends, triglyceride is 310.5mg/100ml before taking, serum total cholesterol 242.65mg/100ml; Taking the back triglyceride is 227.56mg/100ml, serum total cholesterol 201.12mg/100ml.Heart is fidgety have been reduced manyly, now continues to take these health product.
[case 2]: Li Lin, the man 47 years old, lives Yuanbaoshan District Ping Zhuan town, Chifeng City, suffer from hyperlipidemia for many years, took various hypolipidemics, DeGrain was taken the Oleum Hippophae health product after 2 months, warp is at examination in hospital, triglyceride and cholesterol obviously descend, and triglyceride is 291.6mg/100ml before taking, serum total cholesterol 251.35mg/100ml; Taking the back triglyceride is 241.02mg/100ml, serum total cholesterol 180.15mg/100ml.
The specific embodiment
Embodiment 1:
Get purification Fructrs Hippophae seed oil 24kg, lecithin 0.3kg, vitamin E 0.4kg mixes stirring, and homogenate makes active ingredient compositions of the present invention.
Embodiment 2:
Get purification Fructrs Hippophae seed oil 45kg, lecithin 0.8kg, vitamin E 0.6kg mixes stirring, and homogenate makes active ingredient compositions of the present invention.
Embodiment 3:
Get purification Fructrs Hippophae seed oil 48kg, lecithin 0.5kg, vitamin E 0.5kg mixes stirring, and homogenate makes active ingredient compositions of the present invention.By existing soft capsule production technology filled capsules, bottling, again through cobalt 60The width of cloth is packaged into box and promptly makes Oleum Hippophae health product soft capsule according to sterilization.Every of capsule contains active ingredient compositions 1g, instructions of taking: every day 2-3 time, each 1-4 grain.

Claims (3)

1, a kind of Oleum Hippophae health product is characterized in that it is made up of the activated feedstock of following weight portion proportioning: 80~99 parts of purification Fructrs Hippophae seed oil, 0.5~3 part in lecithin, 0.5~3 part of vitamin E.
2, Oleum Hippophae health product according to claim 1, wherein the weight portion proportioning of each activated feedstock is: 90~98 parts of purification Fructrs Hippophae seed oil, 1~2 part in lecithin, vitamin e1~2 part.
3, Oleum Hippophae health product according to claim 1, wherein the weight portion proportioning of each activated feedstock is: 96 parts of purification Fructrs Hippophae seed oil, 1 part in lecithin, vitamin e1 part.
CN 200410042755 2004-05-26 2004-05-26 Health care product of hippophae rhamnoides oil Expired - Fee Related CN1262284C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410042755 CN1262284C (en) 2004-05-26 2004-05-26 Health care product of hippophae rhamnoides oil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410042755 CN1262284C (en) 2004-05-26 2004-05-26 Health care product of hippophae rhamnoides oil

Publications (2)

Publication Number Publication Date
CN1583108A true CN1583108A (en) 2005-02-23
CN1262284C CN1262284C (en) 2006-07-05

Family

ID=34601665

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410042755 Expired - Fee Related CN1262284C (en) 2004-05-26 2004-05-26 Health care product of hippophae rhamnoides oil

Country Status (1)

Country Link
CN (1) CN1262284C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100435663C (en) * 2006-12-18 2008-11-26 东北虎药业股份有限公司 Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method
CN102727872A (en) * 2012-07-13 2012-10-17 荣成百合生物技术有限公司 Anti-aging and heart and blood vessel protecting soft capsule and preparation method thereof
CN102771794A (en) * 2012-07-31 2012-11-14 新疆伊犁州惠华酒业有限责任公司 Soft capsule made of seabuckthorn oil and vitamins EC
CN105816490A (en) * 2016-05-12 2016-08-03 陕西海天制药有限公司 Health care application of sea buckthron oil
CN106420853A (en) * 2016-08-24 2017-02-22 陕西海天制药有限公司 Medical health applications of sea buckthron oil for mucosal repair and nutrition
CN107494763A (en) * 2017-08-02 2017-12-22 林芝 A kind of concentrated sea-buckthorn perilla herb oil
CN107837298A (en) * 2016-09-19 2018-03-27 张黎平 A kind of sea-buckthorn oil health care product

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100435663C (en) * 2006-12-18 2008-11-26 东北虎药业股份有限公司 Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method
CN102727872A (en) * 2012-07-13 2012-10-17 荣成百合生物技术有限公司 Anti-aging and heart and blood vessel protecting soft capsule and preparation method thereof
CN102727872B (en) * 2012-07-13 2014-09-24 威海百合生物技术股份有限公司 Anti-aging and heart and blood vessel protecting soft capsule and preparation method thereof
CN102771794A (en) * 2012-07-31 2012-11-14 新疆伊犁州惠华酒业有限责任公司 Soft capsule made of seabuckthorn oil and vitamins EC
CN105816490A (en) * 2016-05-12 2016-08-03 陕西海天制药有限公司 Health care application of sea buckthron oil
CN106420853A (en) * 2016-08-24 2017-02-22 陕西海天制药有限公司 Medical health applications of sea buckthron oil for mucosal repair and nutrition
CN107837298A (en) * 2016-09-19 2018-03-27 张黎平 A kind of sea-buckthorn oil health care product
CN107494763A (en) * 2017-08-02 2017-12-22 林芝 A kind of concentrated sea-buckthorn perilla herb oil

Also Published As

Publication number Publication date
CN1262284C (en) 2006-07-05

Similar Documents

Publication Publication Date Title
JP2020514338A (en) Ways to Improve Might Fuzzy in a Subject
CN101715913B (en) Capsule for regulating blood fat and production process thereof
BRPI0617988A2 (en) anti-obesity composition, use of melissa extract, use of a mixture of melissa extract and mori folium extract, use of a mixture of melissa extract, artemisia extract and mori folium extract and method to suppress obesity
JP2023100870A (en) Method for improving mitophagy in subject
KR20130041902A (en) Triheptanoin diet for adult polyglucosan body disease (apbd) treatment
CN1262284C (en) Health care product of hippophae rhamnoides oil
CN105087157A (en) Refining process and use of perilla oil for low sterol injection
CN107684554B (en) Application of the butyric acid compound in preparation prevention and treatment NEC drug
CN101879272B (en) Chinese medicinal compound for treating coronary heart diseases, preparation method and application thereof
Upadhyay High Cholesterol Disorders, Myocardial Infarction and Its Therapeutics
CN109381465A (en) Wo Nuolazan is preparing the application in antigout preparation
CN109562089A (en) Lithium benzoate is used to treat the purposes of central nervous system disease
Mishra et al. Role of nutraceuticals in metabolic syndrome
CN106728145A (en) It is a kind of to treat Chinese and western medicinal composition of acute diarrhea and preparation method thereof
CN107837298A (en) A kind of sea-buckthorn oil health care product
CN101850031B (en) Pueraria isoflavone capsule
CN107693598A (en) A kind of compound preparation of reducing blood lipid and preparation method thereof
CN102247572A (en) Medicament for treating hyperlipidemia
CN101347483A (en) Chinese herbal medicinal composition for treating enterogastric disease and preparation method and use
ES2316313B1 (en) NEW THERAPEUTIC USE OF A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF METABOLIC SYNDROME.
RU2114630C1 (en) Antidiabetic agent "samsar"
Sleimi et al. Effect of flax seeds on lipids: Insulin and ghrelin in type 2 diabetic women with metabolic syndrome
KR20090128625A (en) Composition of chlorella vulgaris and red ginseng for enhancing of immune and preventing of stress
CN103768048B (en) Silybin meglumine tablets and effect for reducing fat thereof
Pariwat et al. 30 Days Randomized Ginger Ingestion on Blood Lipid and Sugar Levels in Hypertensive Older Women

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060705